Bulk Pharmaceutical Compounds (Non-Antibiotic/Non-Hormonal)

HS 300390 covers a broad range of bulk medicaments excluding antibiotics, hormones, and alkaloids, primarily traded in pre-retail pharmaceutical supply chains. India and China dominate global supply as leading API and formulation manufacturers, making country of origin verification critical for regulatory compliance under FDA, EMA, and equivalent frameworks. Demand is structurally inelastic due to therapeutic necessity, but supply chain disruptions—particularly API sourcing from concentrated Asian markets—represent a key risk factor for importers.

Recent trade flows

• Trade flow data available on platform

What Logitality tells you for HS 300390

• Import duty rates by origin country — MFN, FTA, anti-dumping, safeguard duties
• Supplier depth — which origins have the most active supply base into your market
• FX movement impact — whether your currency is working for or against you
• AI-generated sourcing decision guide — which origin wins under which condition
• Feedstock and energy cost signals — early warning on supplier price changes
• Compliance flags — hazmat, dual-use, country of origin rules where applicable